Furthermore, clinical studies have established a close association between VEGFA and the progression of chronic kidney disease, and have revealed a synergistic effect between VEGFA and angiopoietin-1 [7, 8].VEGFA-based pharmaceuticals are a crucial therapeutic intervention for renal disease, supported by robust evidence and notable benefits. Here, VEGFA is linked to chronic kidney disease.